Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Gilead Sciences EBITDA 2010-2024 | GILD

Gilead Sciences annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Gilead Sciences EBITDA for the quarter ending September 30, 2024 was $1.578B, a 52.28% decline year-over-year.
  • Gilead Sciences EBITDA for the twelve months ending September 30, 2024 was $3.585B, a 66.78% decline year-over-year.
  • Gilead Sciences 2023 annual EBITDA was $10.298B, a 9.17% increase from 2022.
  • Gilead Sciences 2022 annual EBITDA was $9.433B, a 21.18% decline from 2021.
  • Gilead Sciences 2021 annual EBITDA was $11.968B, a 115.6% increase from 2020.
  
Gilead Sciences Annual EBITDA
(Millions of US $)
2023 $10,298
2022 $9,433
2021 $11,968
2020 $5,551
2019 $5,691
2018 $9,629
2017 $15,410
2016 $18,791
2015 $23,291
2014 $16,315
2013 $4,869
2012 $4,288
2011 $4,092
2010 $4,228
2009 $3,742
Gilead Sciences Quarterly EBITDA
(Millions of US $)
2024-09-30 $1,578
2024-06-30 $3,338
2024-03-31 $-3,632
2023-12-31 $2,301
2023-09-30 $3,307
2023-06-30 $2,346
2023-03-31 $2,344
2022-12-31 $2,795
2022-09-30 $3,362
2022-06-30 $2,554
2022-03-31 $722
2021-12-31 $1,475
2021-09-30 $4,365
2021-06-30 $2,765
2021-03-31 $3,363
2020-12-31 $3,078
2020-09-30 $2,356
2020-06-30 $-2,634
2020-03-31 $2,751
2019-12-31 $1,443
2019-09-30 $-1,126
2019-06-30 $2,778
2019-03-31 $2,596
2018-12-31 $1,502
2018-09-30 $2,981
2018-06-30 $2,636
2018-03-31 $2,510
2017-12-31 $2,688
2017-09-30 $4,109
2017-06-30 $4,552
2017-03-31 $4,061
2016-12-31 $4,337
2016-09-30 $4,698
2016-06-30 $4,822
2016-03-31 $4,934
2015-12-31 $5,899
2015-09-30 $5,863
2015-06-30 $5,889
2015-03-31 $5,640
2014-12-31 $4,605
2014-09-30 $3,748
2014-06-30 $4,678
2014-03-31 $3,284
2013-12-31 $1,325
2013-09-30 $1,217
2013-06-30 $1,227
2013-03-31 $1,100
2012-12-31 $1,180
2012-09-30 $1,115
2012-06-30 $1,127
2012-03-31 $866
2011-12-31 $941
2011-09-30 $1,077
2011-06-30 $1,092
2011-03-31 $983
2010-12-31 $907
2010-09-30 $1,048
2010-06-30 $1,051
2010-03-31 $1,221
2009-12-31 $1,130
2009-09-30 $951
2009-06-30 $814
2009-03-31 $847
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $115.367B $27.116B
Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya, Odefsey, Descovy, Biktarvy and Truvada. The portfolio also includes hepatitis C virus drugs like Harvoni and Epclusa and HBV drug. The first cell therapy approved for the treatment of adult patients with relapsed or refractory large B-cell lymphoma, has diversified Gilead's portfolio. Tecartus, another CAR T-cell therapy, was granted an accelerated approval in the United States for the treatment of relapsed or refractory mantle cell lymphoma. The company is also working on diversifying and growing its business beyond antivirals into other therapeutic areas. Gilead is also making inroads in the oncology space with strategic collaborations and acquisitions.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $141.575B 13.70
Bristol Myers Squibb (BMY) United States $116.275B 49.00
Vertex Pharmaceuticals (VRTX) United States $102.309B 0.00
CSL (CSLLY) Australia $83.807B 0.00
Regeneron Pharmaceuticals (REGN) United States $77.126B 17.56
GSK (GSK) United Kingdom $69.638B 8.06
Argenex SE (ARGX) Netherlands $37.659B 0.00
Alnylam Pharmaceuticals (ALNY) United States $31.657B 0.00
BioNTech SE (BNTX) Germany $27.110B 0.00
Illumina (ILMN) United States $21.573B 78.62
Biogen (BIIB) United States $21.344B 9.17
BeiGene (BGNE) Cayman Islands $17.212B 0.00
Moderna (MRNA) United States $15.158B 0.00
Genmab (GMAB) Denmark $13.441B 19.72
Incyte (INCY) United States $13.262B 0.00
Insmed (INSM) United States $12.602B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.514B 29.05
Bio-Techne Corp (TECH) United States $11.626B 44.89
Sarepta Therapeutics (SRPT) United States $11.364B 102.56
Exact Sciences (EXAS) United States $10.994B 0.00
Vaxcyte (PCVX) United States $10.785B 0.00
QIAGEN (QGEN) Netherlands $10.194B 20.97
Swedish Orphan Biovitrum (BIOVF) Sweden $10.189B 42.09
Exelixis (EXEL) United States $9.507B 21.62
Bio-Rad Laboratories (BIO.B) United States $9.123B 31.00
Intra-Cellular Therapies (ITCI) United States $8.847B 0.00
Roivant Sciences (ROIV) United Kingdom $8.422B 0.00
Ascendis Pharma (ASND) Denmark $8.276B 0.00
Repligen (RGEN) United States $8.094B 105.44
Jazz Pharmaceuticals (JAZZ) Ireland $7.434B 7.27
Revolution Medicines (RVMD) United States $7.412B 0.00
Legend Biotech (LEGN) United States $6.224B 0.00
Nuvalent (NUVL) United States $5.984B 0.00
Halozyme Therapeutics (HALO) United States $5.975B 13.49
Cytokinetics (CYTK) United States $5.767B 0.00
Blueprint Medicines (BPMC) United States $5.726B 0.00
Telix Pharmaceuticals (TLX) Australia $5.295B 0.00
TG Therapeutics (TGTX) United States $5.012B 0.00
Alkermes (ALKS) Ireland $4.807B 16.15
Krystal Biotech (KRYS) United States $4.741B 78.49
Viking Therapeutics (VKTX) United States $4.708B 0.00
Axsome Therapeutics (AXSM) United States $4.397B 0.00
Scholar Rock Holding (SRRK) United States $4.192B 0.00
Apellis Pharmaceuticals (APLS) United States $4.131B 0.00
ADMA Biologics Inc (ADMA) United States $4.113B 43.50
Arcellx (ACLX) United States $4.085B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.083B 0.00
Guardant Health (GH) United States $3.913B 0.00
Avidity Biosciences (RNA) United States $3.796B 0.00
Immunovant (IMVT) United States $3.796B 0.00
Biohaven (BHVN) United States $3.667B 0.00
Alvotech (ALVO) Luxembourg $3.591B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.476B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.449B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.414B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.334B 0.00
NovoCure (NVCR) Jersey $3.333B 0.00
Denali Therapeutics (DNLI) United States $3.087B 0.00
Janux Therapeutics (JANX) United States $2.983B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.945B 0.00
Amicus Therapeutics (FOLD) United States $2.928B 0.00
Edgewise Therapeutics (EWTX) United States $2.915B 0.00
Zai Lab (ZLAB) China $2.903B 0.00
Merus (MRUS) Netherlands $2.865B 0.00
Twist Bioscience (TWST) United States $2.846B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.807B 21.63
Vericel (VCEL) United States $2.789B 941.67
Vera Therapeutics (VERA) United States $2.698B 0.00
SpringWorks Therapeutics (SWTX) United States $2.647B 0.00
Kymera Therapeutics (KYMR) United States $2.633B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.495B 0.00
Protagonist Therapeutics (PTGX) United States $2.473B 15.60
Arrowhead Pharmaceuticals (ARWR) United States $2.420B 0.00
Beam Therapeutics (BEAM) United States $2.402B 0.00
Iovance Biotherapeutics (IOVA) United States $2.249B 0.00
IDEAYA Biosciences (IDYA) United States $2.214B 0.00
CG Oncology (CGON) United States $2.180B 0.00
Ligand Pharmaceuticals (LGND) United States $2.166B 54.08
Apogee Therapeutics (APGE) United States $2.148B 0.00
Bavarian Nordic (BVNRY) Denmark $2.119B 12.99
Geron (GERN) United States $2.110B 0.00
NeoGenomics (NEO) United States $2.106B 0.00
WAVE Life Sciences (WVE) Singapore $2.061B 0.00
Akero Therapeutics (AKRO) United States $2.048B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.023B 0.00
Agios Pharmaceuticals (AGIO) United States $2.020B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.993B 0.00
Belite Bio (BLTE) United States $1.980B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.955B 16.25
Disc Medicine (IRON) United States $1.919B 0.00
MannKind (MNKD) United States $1.889B 48.93
ImmunityBio (IBRX) United States $1.826B 0.00
Galapagos (GLPG) Belgium $1.763B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.755B 0.00
Neumora Therapeutics (NMRA) United States $1.753B 0.00
Fortrea Holdings (FTRE) United States $1.728B 55.03
Certara (CERT) United States $1.724B 48.68
Dynavax Technologies (DVAX) United States $1.672B 97.85
Mesoblast (MESO) Australia $1.670B 0.00
Celldex Therapeutics (CLDX) United States $1.668B 0.00
Structure Therapeutics (GPCR) United States $1.598B 0.00
Viridian Therapeutics (VRDN) United States $1.507B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.487B 0.00
Praxis Precision Medicines (PRAX) United States $1.426B 0.00
Arcus Biosciences (RCUS) United States $1.418B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.417B 0.00
Nurix Therapeutics (NRIX) United States $1.405B 0.00
Novavax (NVAX) United States $1.394B 0.00
Travere Therapeutics (TVTX) United States $1.341B 0.00
MiMedx (MDXG) United States $1.337B 35.00
Day One Biopharmaceuticals (DAWN) United States $1.290B 0.00
Arvinas (ARVN) United States $1.270B 0.00
Intellia Therapeutics (NTLA) United States $1.241B 0.00
Spyre Therapeutics (SYRE) United States $1.227B 0.00
Myriad Genetics (MYGN) United States $1.216B 0.00
ANI Pharmaceuticals (ANIP) United States $1.122B 15.29
Syndax Pharmaceuticals (SNDX) United States $1.116B 0.00
Septerna (SEPN) United States $1.078B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.054B 0.00
Gyre Therapeutics (GYRE) United States $1.042B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.014B 0.00
Vir Biotechnology (VIR) United States $1.011B 0.00
Zymeworks (ZYME) United States $0.974B 0.00
Bicara Therapeutics (BCAX) United States $0.957B 0.00
Adaptive Biotechnologies (ADPT) United States $0.943B 0.00
Liquidia Technologies (LQDA) United States $0.939B 0.00
Poseida Therapeutics (PSTX) United States $0.924B 0.00
Nuvation Bio (NUVB) United States $0.902B 0.00
LENZ Therapeutics (LENZ) United States $0.897B 0.00
ArriVent BioPharma (AVBP) United States $0.879B 0.00
Pacira BioSciences (PCRX) United States $0.876B 8.25
Upstream Bio (UPB) United States $0.869B 0.00
Cogent Biosciences (COGT) United States $0.866B 0.00
Replimune (REPL) United States $0.855B 0.00
89BIO (ETNB) United States $0.843B 0.00
AbCellera Biologics (ABCL) Canada $0.842B 0.00
UniQure (QURE) Netherlands $0.828B 0.00
Prothena (PRTA) Ireland $0.819B 0.00
Immatics (IMTX) Germany $0.818B 0.00
Cytek Biosciences (CTKB) United States $0.814B 0.00
Pliant Therapeutics (PLRX) United States $0.804B 0.00
Avid Bioservices (CDMO) United States $0.787B 0.00
Castle Biosciences (CSTL) United States $0.771B 137.65
Anavex Life Sciences (AVXL) United States $0.732B 0.00
Erasca (ERAS) United States $0.718B 0.00
Tyra Biosciences (TYRA) United States $0.708B 0.00
Dianthus Therapeutics (DNTH) United States $0.704B 0.00
Kura Oncology (KURA) United States $0.701B 0.00
Tectonic Therapeutic (TECX) United States $0.700B 0.00
Keros Therapeutics (KROS) United States $0.690B 0.00
Oculis Holding AG (OCS) Switzerland $0.688B 0.00
CARGO Therapeutics (CRGX) United States $0.686B 0.00
Immunome (IMNM) United States $0.685B 0.00
MBX Biosciences (MBX) United States $0.680B 0.00
Cullinan Therapeutics (CGEM) United States $0.675B 0.00
Rapport Therapeutics (RAPP) United States $0.661B 0.00
Entrada Therapeutics (TRDA) United States $0.658B 11.06
Sinovac Biotech (SVA) China $0.645B 0.00
CureVac (CVAC) Germany $0.643B 5.22
Stoke Therapeutics (STOK) United States $0.619B 0.00
Pharming Group (PHAR) Netherlands $0.617B 0.00
GRAIL (GRAL) United States $0.617B 0.00
Mineralys Therapeutics (MLYS) United States $0.614B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.609B 0.00
Arbutus Biopharma (ABUS) United States $0.608B 0.00
Humacyte (HUMA) United States $0.584B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.579B 0.00
Oric Pharmaceuticals (ORIC) United States $0.579B 0.00
Annexon (ANNX) United States $0.557B 0.00
Astria Therapeutics (ATXS) United States $0.540B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.525B 0.00
CorMedix Inc (CRMD) United States $0.520B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.520B 0.00
Sangamo Therapeutics (SGMO) United States $0.515B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.509B 0.00
Terns Pharmaceuticals (TERN) United States $0.498B 0.00
Third Harmonic Bio (THRD) United States $0.488B 0.00
PureTech Health (PRTC) United States $0.486B 0.00
Abivax SA (ABVX) France $0.485B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.485B 0.00
Cartesian Therapeutics (RNAC) United States $0.483B 0.00
MeiraGTx Holdings (MGTX) United States $0.481B 0.00
Celcuity (CELC) United States $0.463B 0.00
Kodiak Sciences (KOD) United States $0.455B 0.00
MaxCyte (MXCT) United States $0.448B 0.00
AnaptysBio (ANAB) United States $0.443B 0.00
Emergent Biosolutions (EBS) United States $0.439B 0.00
Codexis (CDXS) United States $0.430B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.426B 0.00
ChromaDex (CDXC) United States $0.419B 549.00
Arcturus Therapeutics Holdings (ARCT) United States $0.419B 0.00
Zenas BioPharma (ZBIO) United States $0.418B 0.00
Alumis (ALMS) United States $0.417B 0.00
Alpha Teknova (TKNO) United States $0.412B 0.00
IGM Biosciences (IGMS) United States $0.410B 0.00
Aura Biosciences (AURA) United States $0.410B 0.00
Allogene Therapeutics (ALLO) United States $0.392B 0.00
Prime Medicine (PRME) United States $0.380B 0.00
REGENXBIO (RGNX) United States $0.378B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.371B 0.00
Sana Biotechnology (SANA) United States $0.368B 0.00
GH Research (GHRS) Ireland $0.356B 0.00
Design Therapeutics (DSGN) United States $0.354B 0.00
Olema Pharmaceuticals (OLMA) United States $0.350B 0.00
Contineum Therapeutics (CTNM) United States $0.348B 0.00
Absci (ABSI) United States $0.343B 0.00
Sage Therapeutics (SAGE) United States $0.343B 0.00
Northwest Biotherapeutics (NWBO) United States $0.343B 0.00
Kamada (KMDA) Israel $0.339B 21.07
Neurogene (NGNE) United States $0.336B 0.00
Tango Therapeutics (TNGX) United States $0.333B 0.00
Eton Pharmaceuticals (ETON) United States $0.327B 0.00
Jasper Therapeutics (JSPR) United States $0.324B 0.00
Revance Therapeutics (RVNC) United States $0.323B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.321B 0.00
XOMA Royalty (XOMA) United States $0.320B 0.00
ACELYRIN, INC (SLRN) United States $0.316B 0.00
Voyager Therapeutics (VYGR) United States $0.314B 8.10
Trevi Therapeutics (TRVI) United States $0.311B 0.00
Prima BioMed (IMMP) Australia $0.295B 0.00
Foghorn Therapeutics (FHTX) United States $0.286B 0.00
Candel Therapeutics (CADL) United States $0.284B 0.00
ATyr Pharma (ATYR) United States $0.281B 0.00
C4 Therapeutics (CCCC) United States $0.279B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.279B 0.00
DiaMedica Therapeutics (DMAC) United States $0.274B 0.00
ITeos Therapeutics (ITOS) United States $0.271B 0.00
Artiva Biotherapeutics (ARTV) United States $0.270B 0.00
Atea Pharmaceuticals (AVIR) United States $0.269B 0.00
Chimerix (CMRX) United States $0.269B 0.00
Lifecore Biomedical (LFCR) United States $0.267B 0.00
AC Immune (ACIU) Switzerland $0.265B 0.00
Benitec Biopharma (BNTC) United States $0.265B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.260B 0.00
Renovaro (RENB) United States $0.260B 0.00
EnGene Holdings (ENGN) Canada $0.258B 0.00
Rezolute (RZLT) United States $0.254B 0.00
Urogen Pharma (URGN) United States $0.250B 0.00
Abeona Therapeutics (ABEO) United States $0.248B 0.00
BioStem Technologies (BSEM) $0.240B 21.24
Anika Therapeutics (ANIK) United States $0.239B 0.00
Fulcrum Therapeutics (FULC) United States $0.235B 0.00
Ocugen (OCGN) United States $0.226B 0.00
Precigen (PGEN) United States $0.223B 0.00
Nautilus Biotechnology (NAUT) United States $0.221B 0.00
BioAge Labs (BIOA) United States $0.220B 0.00
Cardiff Oncology (CRDF) United States $0.218B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.215B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.214B 0.00
Inhibrx Biosciences (INBX) United States $0.211B 0.00
Molecular Partners AG (MOLN) Switzerland $0.205B 0.00
Mersana Therapeutics (MRSN) United States $0.198B 0.00
Opthea (OPT) Australia $0.195B 0.00
XBiotech (XBIT) United States $0.194B 0.00
Inozyme Pharma (INZY) United States $0.192B 0.00
Fate Therapeutics (FATE) United States $0.191B 0.00
Gossamer Bio (GOSS) United States $0.190B 0.00
GENFIT S.A (GNFT) France $0.190B 0.00
Compass Therapeutics (CMPX) United States $0.190B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.190B 0.00
TuHURA Biosciences (HURA) United States $0.189B 0.00
Amarin (AMRN) Ireland $0.189B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.187B 0.00
Verastem (VSTM) United States $0.186B 0.00
Checkpoint Therapeutics (CKPT) United States $0.183B 0.00
Alector (ALEC) United States $0.182B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.176B 0.00
Coherus BioSciences (CHRS) United States $0.175B 0.00
Semper Paratus Acquisition (TVGN) United States $0.174B 0.00
Kyverna Therapeutics (KYTX) United States $0.173B 0.00
Bright Minds Biosciences (DRUG) United States $0.171B 0.00
Innate Pharma S.A (IPHA) France $0.170B 0.00
ScPharmaceuticals (SCPH) United States $0.170B 0.00
Elutia (ELUT) United States $0.167B 0.00
Nkarta (NKTX) United States $0.167B 0.00
Solid Biosciences (SLDB) United States $0.166B 0.00
Adherex Technologies (FENC) United States $0.165B 0.00
Cidara Therapeutics (CDTX) United States $0.164B 0.00
Caribou Biosciences (CRBU) United States $0.163B 0.00
Greenwich LifeSciences (GLSI) United States $0.163B 0.00
2seventy Bio (TSVT) United States $0.162B 0.00
TScan Therapeutics (TCRX) United States $0.159B 0.00
Ventyx Biosciences (VTYX) United States $0.158B 0.00
Seres Therapeutics (MCRB) United States $0.156B 0.00
Sutro Biopharma (STRO) United States $0.155B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.155B 0.00
Biomea Fusion (BMEA) United States $0.153B 0.00
Sagimet Biosciences (SGMT) United States $0.152B 0.00
Zura Bio (ZURA) United States $0.149B 0.00
Aligos Therapeutics (ALGS) United States $0.143B 0.00
Compugen (CGEN) Israel $0.137B 76.50
Monopar Therapeutics (MNPR) United States $0.136B 0.00
Seer (SEER) United States $0.136B 0.00
Puma Biotechnology (PBYI) United States $0.135B 5.73
Instil Bio (TIL) United States $0.135B 0.00
Tenaya Therapeutics (TNYA) United States $0.132B 0.00
Actuate Therapeutics (ACTU) United States $0.132B 0.00
InflaRx (IFRX) Germany $0.132B 0.00
Climb Bio (CLYM) United States $0.131B 0.00
Black Diamond Therapeutics (BDTX) United States $0.126B 0.00
Akoya Biosciences (AKYA) United States $0.123B 0.00
Inventiva S.A (IVA) France $0.123B 0.00
PepGen (PEPG) United States $0.118B 0.00
Cabaletta Bio (CABA) United States $0.116B 0.00
Invizyne Technologies (IZTC) United States $0.116B 0.00
TELA Bio (TELA) United States $0.112B 0.00
Leap Therapeutics (LPTX) United States $0.112B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.111B 0.00
Editas Medicine (EDIT) United States $0.108B 0.00
Allakos (ALLK) United States $0.107B 0.00
Abpro Holdings (ABP) United States $0.107B 0.00
MediciNova (MNOV) United States $0.106B 0.00
Alto Neuroscience (ANRO) United States $0.105B 0.00
CAMP4 Therapeutics (CAMP) United States $0.105B 0.00
X4 Pharmaceuticals (XFOR) United States $0.104B 0.00
BioHarvest Sciences (BHST) Canada $0.103B 0.00
Applied Therapeutics (APLT) United States $0.102B 0.00
Adverum Biotechnologies (ADVM) United States $0.099B 0.00
INmune Bio (INMB) United States $0.098B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.096B 0.00
HilleVax (HLVX) United States $0.093B 0.00
Genenta Science S.p.A (GNTA) Italy $0.092B 0.00
Cellectis S.A (CLLS) France $0.091B 0.00
Adagene (ADAG) China $0.091B 0.00
Immunic (IMUX) United States $0.090B 0.00
Coya Therapeutics (COYA) United States $0.088B 0.00
Nuvectis Pharma (NVCT) United States $0.087B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.087B 0.00
Scilex Holding (SCLX) United States $0.086B 0.00
ALX Oncology Holdings (ALXO) United States $0.085B 0.00
23andMe Holding (ME) United States $0.085B 0.00
CytomX Therapeutics (CTMX) United States $0.085B 6.41
Aadi Bioscience (AADI) United States $0.084B 0.00
Bluebird Bio (BLUE) United States $0.083B 0.00
Theratechnologies (THTX) Canada $0.082B 0.00
Skye Bioscience (SKYE) United States $0.082B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.082B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.082B 0.00
Rani Therapeutics Holdings (RANI) United States $0.080B 0.00
Adlai Nortye (ANL) Cayman Islands $0.080B 0.00
Generation Bio (GBIO) United States $0.079B 0.00
Genelux (GNLX) United States $0.078B 0.00
Quince Therapeutics (QNCX) United States $0.078B 0.00
FibroBiologics (FBLG) United States $0.078B 0.00
Alpha Cognition (ACOG) Canada $0.077B 0.00
I-Mab (IMAB) China $0.075B 0.00
Entera Bio (ENTX) Israel $0.075B 0.00
Adicet Bio (ACET) United States $0.075B 0.00
Ikena Oncology (IKNA) United States $0.075B 0.00
Aerovate Therapeutics (AVTE) United States $0.073B 0.00
Ovid Therapeutics (OVID) United States $0.071B 0.00
Werewolf Therapeutics (HOWL) United States $0.071B 0.00
VistaGen Therapeutics (VTGN) United States $0.070B 0.00
Vigil Neuroscience (VIGL) United States $0.070B 0.00
ZIVO Bioscience (ZIVO) United States $0.067B 0.00
Agenus (AGEN) United States $0.066B 0.00
Clearside Biomedical (CLSD) United States $0.066B 0.00
Atara Biotherapeutics (ATRA) United States $0.066B 0.00
DBV Technologies S.A (DBVT) France $0.066B 0.00
Oncolytics Biotech (ONCY) Canada $0.064B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.064B 0.00
Cue Biopharma (CUE) United States $0.064B 0.00
Galena Biopharma (SLS) United States $0.063B 0.00
Immuneering (IMRX) United States $0.062B 0.00
BeyondSpring (BYSI) United States $0.062B 0.00
PDS Biotechnology (PDSB) United States $0.062B 0.00
BGM Group (BGM) China $0.061B 0.00
Annovis Bio (ANVS) United States $0.060B 0.00
Immix Biopharma (IMMX) United States $0.060B 0.00
Vor Biopharma (VOR) $0.060B 0.00
Kronos Bio (KRON) United States $0.058B 0.00
Boundless Bio (BOLD) United States $0.058B 0.00
Xilio Therapeutics (XLO) United States $0.056B 0.00
Repare Therapeutics (RPTX) Canada $0.056B 0.00
Shattuck Labs (STTK) United States $0.055B 0.00
Invivyd (IVVD) United States $0.053B 0.00
Elicio Therapeutics (ELTX) United States $0.053B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.053B 0.00
Connect Biopharma Holdings (CNTB) United States $0.053B 0.00
Spero Therapeutics (SPRO) United States $0.052B 13.64
Dyadic (DYAI) United States $0.052B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.052B 0.00
Celularity (CELU) United States $0.051B 0.00
IO Biotech (IOBT) Denmark $0.051B 0.00
Exicure (XCUR) United States $0.049B 0.00
Inovio Pharmaceuticals (INO) United States $0.048B 0.00
VTv Therapeutics (VTVT) United States $0.048B 0.00
Fortress Biotech (FBIO) United States $0.047B 0.00
Kezar Life Sciences (KZR) United States $0.047B 0.00
Omega Therapeutics (OMGA) United States $0.046B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.045B 0.00
Q32 Bio (QTTB) United States $0.044B 0.00
SAB Biotherapeutics (SABS) United States $0.043B 0.00
Estrella Immunopharma (ESLA) United States $0.042B 0.00
Passage Bio (PASG) United States $0.041B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.040B 0.00
Enzo Biochem (ENZ) United States $0.040B 0.00
Rallybio (RLYB) United States $0.039B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.039B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.039B 0.00
Lexaria Bioscience (LEXX) Canada $0.039B 0.00
Grace Therapeutics (GRCE) Canada $0.039B 0.00
Aileron Therapeutics (ALRN) United States $0.038B 0.00
AN2 Therapeutics (ANTX) United States $0.038B 0.00
CalciMedica (CALC) United States $0.037B 0.00
Clene (CLNN) United States $0.037B 0.00
Precision BioSciences (DTIL) United States $0.036B 0.00
OKYO Pharma (OKYO) $0.036B 0.00
Elevation Oncology (ELEV) United States $0.034B 0.00
Oncobiologics (OTLK) United States $0.034B 0.00
Lantern Pharma (LTRN) United States $0.034B 0.00
BioAtla (BCAB) United States $0.033B 0.00
Opus Genetics (IRD) United States $0.031B 0.00
Promis Neurosciences (PMN) Canada $0.030B 0.00
RenovoRx (RNXT) United States $0.030B 0.00
Beyond Air (XAIR) United States $0.029B 0.00
Rapt Therapeutics (RAPT) United States $0.029B 0.00
Intensity Therapeutics (INTS) United States $0.028B 0.00
Forte Biosciences (FBRX) United States $0.028B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.028B 0.00
OnKure Therapeutics (OKUR) United States $0.028B 0.00
Medicus Pharma (MDCX) Canada $0.028B 0.00
LakeShore Biopharma (LSB) China $0.028B 0.00
KALA BIO (KALA) United States $0.027B 0.00
NextCure (NXTC) United States $0.027B 0.00
Cadrenal Therapeutics (CVKD) United States $0.027B 0.00
Pluri (PLUR) Israel $0.027B 0.00
Cognition Therapeutics (CGTX) United States $0.026B 0.00
Curis (CRIS) United States $0.026B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.026B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.026B 0.00
Femasys (FEMY) United States $0.025B 0.00
BRIACELL THERAP (BCTX) Canada $0.025B 0.00
Longeveron (LGVN) United States $0.024B 0.00
Gelteq (GELS) Australia $0.024B 0.00
HOOKIPA Pharma (HOOK) United States $0.024B 0.00
Chemomab Therapeutics (CMMB) Israel $0.024B 0.00
Dare Bioscience (DARE) United States $0.024B 0.00
Cara Therapeutics (CARA) United States $0.023B 0.00
Ocean Biomedical (OCEA) United States $0.023B 0.00
Cocrystal Pharma (COCP) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
NKGen Biotech (NKGN) United States $0.023B 0.00
Athira Pharma (ATHA) United States $0.022B 0.00
Pulmatrix (PULM) United States $0.022B 0.00
GeoVax Labs (GOVX) United States $0.022B 0.00
Equillium (EQ) United States $0.022B 0.00
MiNK Therapeutics (INKT) United States $0.021B 0.00
Bionano Genomics (BNGO) United States $0.020B 0.00
Affimed (AFMD) Germany $0.019B 0.00
Bolt Biotherapeutics (BOLT) United States $0.019B 0.00
Tenax Therapeutics (TENX) United States $0.019B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.019B 0.00
Senti Biosciences (SNTI) United States $0.018B 0.00
Cyclo Therapeutics (CYTH) United States $0.018B 0.00
IN8bio (INAB) United States $0.018B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.018B 0.00
HCW Biologics (HCWB) United States $0.017B 0.00
Aptose Biosciences (APTO) Canada $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Aprea Therapeutics (APRE) United States $0.017B 0.00
Spruce Biosciences (SPRB) United States $0.017B 0.00
UNITY Biotechnology (UBX) United States $0.016B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
Pieris Pharmaceuticals (PVLA) United States $0.016B 0.00
BioAffinity Technologies (BIAF) United States $0.015B 0.00
BioXcel Therapeutics (BTAI) United States $0.015B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.014B 0.00
MetaVia (MTVA) United States $0.014B 0.00
CervoMed (CRVO) United States $0.014B 0.00
Mainz Biomed (MYNZ) Germany $0.013B 0.00
Cingulate (CING) United States $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.013B 0.00
Imunon (IMNN) United States $0.012B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Apollomics (APLM) United States $0.011B 0.00
Ensysce Biosciences (ENSC) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.009B 0.00
BioCardia (BCDA) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Aytu BioPharma (AYTU) United States $0.008B 0.00
Mustang Bio (MBIO) United States $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Soligenix (SNGX) United States $0.007B 0.00
Eyenovia (EYEN) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Vincerx Pharma (VINC) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Elevai Labs (ELAB) United States $0.007B 0.00
GRI Bio (GRI) United States $0.007B 0.00
Polyrizon (PLRZ) Israel $0.007B 0.00
Portage Biotech (PRTG) $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Galecto (GLTO) Denmark $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Edesa Biotech (EDSA) Canada $0.006B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.006B 0.00
Quantum Biopharma (QNTM) Canada $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Evaxion Biotech (EVAX) Denmark $0.005B 0.00
Syros Pharmaceuticals (SYRS) United States $0.005B 0.00
Moleculin Biotech (MBRX) United States $0.005B 0.00
Carmell (CTCX) United States $0.005B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Allarity Therapeutics (ALLR) United States $0.004B 0.00
Bionomics (BNOX) Australia $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
NAYA Biosciences (NAYA) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
AquaBounty Technologies (AQB) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00